Search

everythinglearnresearchcommunity

for

Search:↓

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

A new antiandrogen compound was made and its detailed three-dimensional shape was described.

Ethanamizuril is safe for rats at 20 mg/kg feed, but higher doses cause hair loss, organ changes, and liver, kidney, and lung damage.

Ozenoxacin reduces sebum production, helping manage acne.

A rigid compound with a common structural motif was successfully synthesized.

Topical thiols may prevent hair loss caused by certain chemotherapy drugs.

A new method efficiently modifies alkenes to create useful medicinal compounds.

Hyaluronic acid microneedles help deliver minoxidil derivatives effectively for hair regrowth.

Fetal exposure to diazoxide can cause hair loss and abnormal hair growth in infants.

Sulphadiazine can cause crystals to form in urine.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

New sulfur-containing steroid analogs show promise for more targeted medical treatments.

New pyrazole derivatives may help treat hair loss, but more testing is needed.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

Ozenoxacin 1% cream is an effective and safe treatment for impetigo in children and adults.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

Metformin and thiazolidinediones are similarly effective for PCOS, but metformin is often preferred due to fewer side effects.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

The salts have diverse molecular packing with significant hydrogen interactions.

OXTR agonists may promote hair growth and be effective for treating hair loss.

Midazolam impairs learning and memory by increasing neurosteroids through specific receptor activation.

Topical sulfonylurea may reduce excessive hair growth caused by certain medications.

Minoxidil analogs can be improved for hair growth inhibition by modifying specific parts of their structure.

The new compound may be a safer alternative to finasteride for prostate protection.